We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+2.19%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$1.12B
AUM Growth
+$146M
Cap. Flow
-$6.04M
Cap. Flow %
-0.54%
Top 10 Hldgs %
16.93%
Holding
462
New
136
Increased
57
Reduced
41
Closed
111

Sector Composition

Rank Sector Weight
1 Financials 29.94%
2 Healthcare 10.97%
3 Technology 7.15%
4 Communication Services 3.95%
5 Industrials 3.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPAR
301
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
$954K 0.09%
+98,051
New +$952K
PSQH icon
302
PSQ Holdings
PSQH
$13.9M
$940K 0.08%
+6,482
New +$937K
GNAC
303
DELISTED
Group Nine Acquisition Corp. Class A Common stock
GNAC
$882K 0.08%
90,587
KAIR
304
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
$870K 0.08%
90,010
FRW
305
DELISTED
PWP Forward Acquisition Corp. I Class A Common Stock
FRW
$867K 0.08%
90,175
CLAA
306
DELISTED
Colonnade Acquisition Corp. II
CLAA
$817K 0.07%
83,565
-3,700
-4% -$36.1K
MONDW
307
DELISTED
Mondee Holdings, Inc. Warrant
MONDW
$807K 0.07%
82,758
-96,834
-54% -$62.1K
HLAH
308
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Class A Common Stock
HLAH
$732K 0.07%
75,498
-24,501
-25% -$238K
RCHG
309
DELISTED
Recharge Acquisition Corp. Class A Common Stock
RCHG
$713K 0.06%
71,999
-228,001
-76% -$2.24M
FLYX icon
310
flyExclusive
FLYX
$59.5M
$701K 0.06%
+72,220
New +$699K
MACA
311
DELISTED
Moringa Acquisition Corp Class A Ordinary Shares
MACA
$695K 0.06%
71,669
-128,331
-64% -$1.24M
ML.WS
312
DELISTED
MoneyLion Inc. Warrants, each whole warrant exercisable 1/30th of a share of Class A common stock at an exercise price of $345.00 per whole share
ML.WS
$657K 0.06%
+97,000
New +$108K
YAC
313
DELISTED
Yucaipa Acquisition Corporation Class A Ordinary Shares
YAC
$609K 0.05%
+61,601
New +$608K
JATT.U
314
DELISTED
JATT Acquisition Corp Units, each consisting of one Class A ordinary share, and one-half of one redeemable warrant
JATT.U
$581K 0.05%
+57,902
New +$580K
CPLG
315
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$574K 0.05%
+37,029
New +$511K
AAQC
316
DELISTED
Accelerate Acquisition Corp
AAQC
$566K 0.05%
+58,181
New +$563K
ZGYHW
317
DELISTED
Yunhong International Warrant
ZGYHW
$532K 0.05%
+51,843
New +$21.6K
GETR
318
DELISTED
Getaround, Inc.
GETR
$479K 0.04%
48,981
-8,764
-15% -$85.4K
IPVI
319
DELISTED
InterPrivate IV InfraTech Partners Inc. Class A Common Stock
IPVI
$478K 0.04%
49,330
-48,530
-50% -$473K
VLAT
320
DELISTED
Valor Latitude Acquisition Corp. Class A Ordinary Shares
VLAT
$464K 0.04%
47,591
+24,102
+103% +$233K
KWAC.WS
321
DELISTED
Kingswood Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common
KWAC.WS
$449K 0.04%
+44,538
New +$26.1K
SBEA
322
DELISTED
SilverBox Engaged Merger Corp I Class A Common Stock
SBEA
$428K 0.04%
43,798
-156,200
-78% -$1.52M
GAPA.WS
323
DELISTED
G&P Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
GAPA.WS
$423K 0.04%
42,870
-37,188
-46% -$22.9K
AVIR icon
324
PUT
Atea Pharmaceuticals
AVIR
$379M
$421K 0.04%
+12,000
New +$333K
SCLE
325
DELISTED
Broadscale Acquisition Corp. Class A common stock
SCLE
$407K 0.04%
41,800
+5,900
+16% +$57.2K

Similar funds

Mangrove Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Mangrove Partners held 462 positions worth $1.12B, up 15% from $971M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Mangrove Partners's Q3 2021 filing shows 136 new, 57 increased, 41 reduced and 111 closed positions. Its largest new stake was Biogen: 45,872 shares worth $13M. The largest sale was Macquarie Infrastructure Holdings, LLC, an estimated $32.2M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 37% a quarter earlier, followed by Healthcare and Technology.

  • Mangrove Partners's largest Q3 2021 buy was Biogen: 45,872 shares worth $13M.
  • Mangrove Partners added most to Travere Therapeutics in Q3 2021, an estimated $6.57M increase.
  • Mangrove Partners's biggest Q3 2021 reduction was Pershing Square Tontine Holdings, Ltd., cutting an estimated $12.8M.
  • Mangrove Partners fully exited Macquarie Infrastructure Holdings, LLC in Q3 2021, selling an estimated $32.2M.
  • Mangrove Partners's ten largest holdings make up 17% of its $1.12B portfolio in Q3 2021.
  • Mangrove Partners opened 136 new positions and closed 111 in Q3 2021.
  • Mangrove Partners's portfolio value rose 15% quarter-over-quarter to $1.12B.

Based on Mangrove Partners's 13F filing for Q3 2021, filed 15 Nov 2021.